丁苯酞对脑梗死再灌注患者血清s-100β蛋白、NSE及神经功能缺损的影响

Influence of Butylbenzene on Serum S-100βProtein,NSE and Neurologic Impairment of Patients with Cerebral Infarction Reperfusion

探讨丁苯酞对脑梗死再灌注患者血清s-100β蛋白、NES及神经功能缺陷的影响。选取106例脑梗死再灌注患者,因治疗方案的不同,将其分为常规治疗组与丁苯酞治疗组,每组各53例。常规治疗组采用常规治疗方法,丁苯酞治疗组采用丁苯酞进行治疗,比较两组患者的临床疗效。结果表明,经治疗干预后,丁苯酞治疗组的血清s-100β蛋白与NSE水平显著低于常规治疗组,丁苯酞治疗组的NIHSS评分显著低于常规治疗组(P<0.05)。结论:应用丁苯酞能够有效降低脑梗死再灌注患者的血清s-100β蛋白与NSE水平,恢复脑梗死再灌注患者的神经功能。

The research explores the influence of butylbenzene on serum s-100βprotein,NSE and neurologic impairment of patients with cerebral infarction reperfusion.106 patients with cerebral infraction reperfusion are divided intro routine group and butylbenzene treatment group according to different treatment schemes,with 53 patients in each group.Routine group receive routine treatment method,and Butylbenzene group receive butylbenzene treatment.Clinical effects of two groups are compared.After intervention,serum s-100βprotein,NSE and NIHSS score of butylbenzene group are significantly lower in routine treatment group(P<0.05).Butylbenzene can effectively decrease serum s-100βprotein and NSE level,and recover neurological function of patients with cerebral infarction reperfusion.